Skip to main content

Table 2 All-cause and cause-specific mortality by fatty liver index

From: The association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study

Fatty liver index

Number

Death

PYs

Incidence rate (per 1000 PY)

Hazard ratio (95% confidence interval)

Model 1

Model 2

All Cause of mortality

  < 30

813,691

103,961

6274880.77

16.57

1(Ref.)

1(Ref.)

 30–59

678,049

72,774

5298066.55

13.74

0.87 (0.86,0.88)

0.88 (0.87,0.89)

  ≥ 60

516,035

45,507

4021847.66

11.31

0.99 (0.98,1.01)

1.02 (1.01,1.03)

CVD-specific mortality

  < 30

813,691

22,307

6274880.77

3.55

1(Ref.)

1(Ref.)

 30–59

678,049

15,910

5298066.55

3.00

0.92 (0.90,0.94)

0.92 (0.90,0.94)

  ≥ 60

516,035

9,351

4021847.66

2.33

1.03 (1.01,1.06)

1.07 (1.04,1.10)

Cancer-specific mortality

  < 30

813,691

27,417

6274880.77

4.37

1(Ref.)

1(Ref.)

 30–59

678,049

22,670

5298066.55

4.28

0.99 (0.97,1.01)

0.99 (0.97,1.01)

  ≥ 60

516,035

15,247

4021847.66

3.79

1.13 (1.11,1.16)

1.12 (1.09,1.14)

Respiratory disease-related mortality

  < 30

813,691

12,210

6274880.77

1.95

1 (Ref.)

1 (Ref.)

 30–59

678,049

6,235

5298066.55

1.18

0.67 (0.65, 0.69)

0.71 (0.69, 0.73)

  ≥ 60

516,035

3,289

4021847.66

0.82

0.71 (0.68, 0.73)

0.80 (0.77, 0.84)

Liver disease-related mortality

  < 30

813,691

2,775

6274880.77

0.44

1(Ref.)

1(Ref.)

 30–59

678,049

3,568

5298066.55

0.67

1.47 (1.40,1.55)

1.46 (1.39,1.53)

  ≥ 60

516,035

4,264

4021847.66

1.06

2.80 (2.66,2.94)

2.63 (2.50,2.77)

  1. Model 1 was adjusted for age and sex; Model 2 was adjusted for smoking status, alcohol consumption, physical activity, low income, alanine aminotransferase, hypertension, dyslipidemia, Charlson comorbidity index, diabetes complication, and diabetes duration and in addition to covariates in model 1
  2. PY person year, CVD cardiovascular diseases